Millennium Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-345,100
| Closed | -$1.05M | – | 3984 |
|
|
2019
Q3 | $1.05M | Sell |
345,100
-486,925
| -59% | -$1.48M | ﹤0.01% | 2307 |
|
|
2019
Q2 | $1.98M | Buy |
832,025
+136,536
| +20% | +$325K | ﹤0.01% | 2031 |
|
|
2019
Q1 | $2.61M | Sell |
695,489
-357,252
| -34% | -$1.34M | ﹤0.01% | 1877 |
|
|
2018
Q4 | $3.78M | Sell |
1,052,741
-100,387
| -9% | -$360K | 0.01% | 1582 |
|
|
2018
Q3 | $6.61M | Buy |
1,153,128
+818,711
| +245% | +$4.69M | 0.01% | 1427 |
|
|
2018
Q2 | $1.68M | Sell |
334,417
-428,879
| -56% | -$2.15M | ﹤0.01% | 2225 |
|
|
2018
Q1 | $3.92M | Buy |
763,296
+19,628
| +3% | +$101K | 0.01% | 1822 |
|
|
2017
Q4 | $4.47M | Buy |
743,668
+33,893
| +5% | +$204K | 0.01% | 1679 |
|
|
2017
Q3 | $3.94M | Buy |
709,775
+586,690
| +477% | +$3.26M | 0.01% | 1662 |
|
|
2017
Q2 | $571K | Sell |
123,085
-130,299
| -51% | -$604K | ﹤0.01% | 2520 |
|
|
2017
Q1 | $1.25M | Sell |
253,384
-26,007
| -9% | -$129K | ﹤0.01% | 2061 |
|
|
2016
Q4 | $3.1M | Buy |
279,391
+204,054
| +271% | +$2.26M | 0.01% | 1513 |
|
|
2016
Q3 | $698K | Sell |
75,337
-122,171
| -62% | -$1.13M | ﹤0.01% | 2233 |
|
|
2016
Q2 | $1.25M | Buy |
197,508
+82,934
| +72% | +$527K | ﹤0.01% | 1834 |
|
|
2016
Q1 | $747K | Buy |
114,574
+2,147
| +2% | +$14K | ﹤0.01% | 2107 |
|
|
2015
Q4 | $912K | Sell |
112,427
-45,970
| -29% | -$373K | ﹤0.01% | 2157 |
|
|
2015
Q3 | $1.16M | Buy |
158,397
+131,518
| +489% | +$964K | ﹤0.01% | 2030 |
|
|
2015
Q2 | $276K | Sell |
26,879
-30,021
| -53% | -$308K | ﹤0.01% | 2712 |
|
|
2015
Q1 | $526K | Buy |
+56,900
| New | +$526K | ﹤0.01% | 2466 |
|
|
2014
Q4 | – | Sell |
-34,533
| Closed | -$188K | – | 3475 |
|
|
2014
Q3 | $188K | Buy |
+34,533
| New | +$188K | ﹤0.01% | 2696 |
|